Author

Koichi Tachibana

Observed name: Koichi TACHIBANA

Institutions: Kirin (Japan), National Institute of Infectious Diseases, Kirin Brewery Company, Limited (Japan)

Observed institutions: Kirin (Japan), National Institute of Infectious Diseases, Wakamoto Pharmaceutical (Japan), Kirin Brewery Company, Limited (Japan)

OpenAlex ID: A5111595114

Regioselective Polyprenyl Rearrangement of Polyprenyl 2,3,4,5-tetrasubstituted Phenyl Ethers Promoted by Boron Trifluoride

1982 · Toyokichi Yoshizawa, Hatsunori Toyofuku, et al. · Chemistry Letters · 26

A potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor

2003 · Kouji Kusano, Shinji Ebara, et al. · Blood · 16

ANTIALLERGIC PROPERTIES OF AN ORALLY EFFECTIVE AGENT, [[3-(1H-TETRAZOL-5-YL}-PHENYL] AMINO] OXOACETIC ACID n-BUTYL ESTER

1982 · Mitsuji AGATA, Hiroshi GOTO, et al. · The Japanese Journal of Pharmacology · 4

Measurement of Cholesterol Efflux from Monocyte-Derived Macrophages of Patients with Llpid Disorders and Atherosclerotic Cardiovascular Diseases

2003 · Kenichi Tsujii, Ken‐ichi Hirano, et al. · Japanese Circulation Journal-english Edition · 1

In Vitro Effect of Introduction of Cholesterol Efflux-Related Molecules on Lipid Metabolism and Transport in Human Monocytes-Derived Macrophages

2003 · Ken‐ichi Hirano, Zhongyan Zhang, et al. · Japanese Circulation Journal-english Edition

Regulatory mechanism of a novel mucociliary clearance remedy (SS320A).

1996 · Koji Kusano, Hiroyuki Naitoh, et al. · The Japanese Journal of Pharmacology

Works count: 6

Citation count: 47

H-index: 3

I10-index: 2